Martin Klaus
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Triple Renin-Angiotensin System/Sodium-Glucose Transporter 2/Glycogen Synthase Kinase-3 β Inhibition for the Progression of CKD in Col4a3 -/- Mice with Alport Nephropathy.
Journal: Kidney360
Published: November 07, 2025
Estrogen-regulated renal progenitors determine pregnancy adaptation and preeclampsia.
Journal: Science (New York, N.Y.)
Published: September 04, 2025
Changes in renal function parameters after cotrimoxazole therapy
Journal: Innere Medizin (Heidelberg, Germany)
Published: May 22, 2025
Oral Ketone β -Hydroxybutyrate Supplement Retards the Loss of GFR in Alport Mice on Dual Renin-Angiotensin System/Sodium-Glucose Transporter 2 Blockade.
Journal: Kidney360
Published: October 17, 2024
Acute kidney failure reveals primary renal non-Hodgkin lymphoma.
Journal: BMJ case reports
Published: April 03, 2024
GDF-15 Suppresses Puromycin Aminonucleoside-Induced Podocyte Injury by Reducing Endoplasmic Reticulum Stress and Glomerular Inflammation.
Journal: Cells
Published: February 12, 2024
No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice.
Journal: Frontiers in immunology
Published: May 27, 2023
Finerenone Added to RAS/SGLT2 Blockade for CKD in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice.
Journal: Journal of the American Society of Nephrology : JASN
Published: April 20, 2023
Deep learning-based molecular morphometrics for kidney biopsies.
Journal: JCI insight
Published: October 01, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026